Senate Health Committee advances insulin cap, prenatal vitamin testing, CalAIM provider changes and other health bills

The California Senate Committee on Health on Oct. 27 advanced a package of health bills affecting millions of Californians, approving measures to cap insulin out‑of‑pocket costs, require testing and public disclosure for prenatal vitamins, strengthen Medi‑Cal contracting for community‑based providers under CalAIM, increase oversight of the state's Comprehensive Perinatal Services Program (CPSP), and limit automatic virtual‑card payment fees for dental providers.

Why it matters: The measures touch both clinical safety and access — the insulin cap addresses immediate affordability and life‑threatening medicine access, the prenatal‑vitamin measure aims to increase consumer transparency about heavy‑metal contaminants, and the CalAIM and CPSP items seek to preserve and expand services for Medi‑Cal enrollees and pregnant people who rely on state programs.

Insulin affordability (SB 40) Senate Bill 40, authored by Sen. Scott Wiener, would cap monthly out‑of‑pocket costs for insulin at $35 for health plans regulated at the state level. Wiener told the committee the bill is intended to mirror the $35 cap set for Medicare beneficiaries and to reduce life‑threatening insulin rationing. “If you don't take it, you will not be able to survive,” Wiener said.

Physicians and patient advocates testified in support, describing patients who skip or ration doses because of cost. Dr. Shagun Bhendesh, a diabetologist, told the committee she had “patients who ration their insulin to make it through the month,” and said the bill is “about dignity” and preventing avoidable suffering. Christine Falabel of the American Diabetes Association noted that California has millions living with diabetes and cited research showing one in six people with diabetes ration insulin because of cost.

Committee members discussed how SB 40 would coexist with California’s CalRx/CalRx‑type state manufacturing efforts; supporters and authors said the two approaches are complementary. The committee approved the bill as amended and referred it to the Appropriations Committee. Motion: do pass as amended and refer to Appropriations (mover: Sen. Richard Rubio). Final recorded committee tally on the day: 11–0 (aye 11, no 0). Outcome: approved by committee and referred for further fiscal review.

Prenatal‑vitamin testing and disclosure (SB 646) Sen. Sydney K. Weber‑Pearson presented SB 646, which would require manufacturers of prenatal vitamins sold in California to test products for specified toxic elements (including lead, arsenic, cadmium and mercury), to post batch‑level results online and to provide a QR code on packaging linking to test results and public information. The bill would require manufacturers to…